ctrl K

Price Alert

Apimeds Pharmaceuticals U... (APUS)

NYSE: APUS · Real-Time Price · USD

1.76

-0.14 (-7.37%)

At close: Aug 20, 2025, 1:12 PM

Apimeds Pharmaceuticals US Inc Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.46K	410.48K	6.17K	171.44K
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	9.6K	11.6K	n/a	n/a
Total Current Assets	13.06K	422.08K	6.17K	172.17K
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a
Total Assets	13.06K	422.08K	6.17K	172.17K
Account Payables	n/a	n/a	36.88K	10.65K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	250K	n/a	260K	n/a
Other Current Liabilities	180.55K	n/a	n/a	n/a
Total Current Liabilities	1.02M	123.31K	319.78K	10.65K
Long-Term Debt	346.84K	266.89K	400K	400K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	346.84K	266.89K	400K	400K
Total Liabilities	1.37M	390.2K	719.78K	410.65K
Total Debt	596.84K	266.89K	660K	400K
Common Stock	79.04K	205.5K	100K	100K
Retained Earnings	-4.39M	-3M	-2.22M	-1.56M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	-1.36M	31.87K	-713.61K	-238.48K
Total Investments	n/a	n/a	n/a	n/a